Format

Send to:

Choose Destination
See comment in PubMed Commons below
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Oct;20(5):1289-92.

[Therapeutics of Burkitt lymphoma in adults - review].

[Article in Chinese]

Author information

  • 1Department of Hematology (Key Medical Discipline), Zhongda Hospital, Southeast University Medical School, Nanjing, Jiangsu Province, China.

Abstract

Burkitt lymphoma is a highly aggressive non-Hodgkin's lymphoma. As Burkitt lymphoma cells are very sensitive to chemotherapy, chemotherapy is the major therapeutic schedule for this disease. Rituximab raised the overall survival rate markedly. Bone marrow transplant, surgery and radiotherapy also demonstrated to have a supporting role for patients with Burkitt lymphoma. This review focus on research progress of the therapeutics and major regimens for the disease.

PMID:
23114166
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk